Abstract
Purpose
Tumour stage is the strongest prognostic parameter in colorectal cancer. The study aimed to evaluate the prognostic impact of pT2, pT3, and pT4 sub-classification.
Methods
Three hundred eighty-one surgical colorectal cancer specimens were retrospectively re-evaluated. pT2 tumours were sub-classified according to infiltration of the inner circumferential (pT2a) or outer longitudinal (pT2b) layer of the muscularis propria. pT3 tumours were sub-classified by measuring the maximal tumour invasion beyond the outer border of the muscularis propria (pT3a ≤ 1 mm, pT3b > 1–5 mm, pT3c > 5–15 mm, and pT3d > 15 mm). pT4 tumours were sub-classified according to invasion of other organs or structures (pT4a) or perforation of the visceral peritoneum (pT4b). Data were correlated with other pathological parameters and patient outcome.
Results
Seventy pT2 tumours were re-classified as 37 pT2a and 33 pT2b tumours. There was no significant association with tumour grade, angioinvasion, or lymph node involvement and no significant impact on prognosis. Two hundred eighteen pT3 tumours were re-classified as 49 pT3a, 83 pT3b, 53 pT3c, and 33 pT3d tumours. pT3 sub-classification was significantly associated with tumour grade, angioinvasion, and lymph node involvement and proved to be an independent prognostic variable with respect to progression-free and cancer-specific survival. A cut-off level of 5 mm is recommended. Sixty-five pT4 tumours were re-classified as 15 pT4a and 50 pT4b tumours. There was no significant association with tumour grade, angioinvasion, or lymph node involvement and no significant impact on prognosis.
Conclusions
pT3 sub-classification was significantly associated with patient outcome. In contrast, pT2 and pT4 sub-classification did not show clinical significance.
Similar content being viewed by others
References
Compton CC (2007) Optimal pathologic staging: defining stage II disease. Clin Cancer Res 13:6862s–6870s
Compton CC (2006) Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med 130:318–324
Quirke P, Williams GT, Ectors N et al (2007) The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol 8:651–657
Rosen LS, Bilchik AJ, Beart RW Jr et al (2007) New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference. Clin Cancer Res 13:6853s–6856s
Cawthorn SJ, Parums DV, Gibbs NM et al (1990) Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 335:1055–1059
Willett CG, Badizadegan K, Ancukiewicz M et al (1999) Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 42:167–173
Merkel S, Mansmann U, Siassi M et al (2001) The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 16:298–304
Merkel S, Wein A, Günther K et al (2001) High-risk groups of patients with Stage II colon carcinoma. Cancer 92:1435–1443
Steel MC, Woods R, Mackay JM et al (2002) Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. ANZ J Surg 72:483–487
Shinto E, Ueno H, Hashiguchi Y et al (2004) The subserosal elastic lamina: an anatomic landmark for stratifying pT3 colorectal cancer. Dis Colon Rectum 47:467–473
Harewood GC, Kumar KS, Clain JE et al (2004) Clinical implications of quantification of mesorectal tumour invasion by endoscopic ultrasound: All T3 rectal cancers are not equal. J Gastroenterol Hepatol 19:750–755
Eriksen MT, Wibe A, Haffner J et al (2007) Prognostic groups in 1, 676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 50:156–167
Miyoshi M, Ueno H, Hashiguchi Y et al (2006) Extent of mesorectal tumour invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg 243:492–498
Cianchi F, Messerini L, Comin CE et al (2007) Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model. Dis Colon Rectum 50:1332–1341
Wittekind Ch, Greene FL, Henson DE, Hutter RVP (eds) (2003) TNM supplement: a commentary on uniform use, 3rd edn. Wiley-Liss inc., New York
Newland RC, Chapuis PH, Smyth EJ (1987) The prognostic value of substaging colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer 60:852–857
Newland RC, Dent OF, Chapuis PH et al (1995) Survival after curative resection of lymph node negative colorectal carcinoma. A prospective study of 910 patients. Cancer 76:564–571
Bokey EL, Chapuis PH, Dent OF et al (2003) Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum 46:860–866
Burdy G, Panis Y, Alves A et al (2001) Identifying patients with T3–T4 node-negative colon cancer at high risk of recurrence. Dis Colon Rectum 44:1682–1688
Shepherd NA, Baxter KJ, Love SB et al (1997) The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 112:1096–1102
Petersen VC, Baxter KJ, Love SB et al (2002) Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 51:65–69
Chapuis PH, Dent OF, Bokey EL et al (2004) Adverse histopathological findings as a guide to patient management after curative resection of node-positive colonic cancer. Br J Surg 91:349–354
Shepherd NA, Baxter KJ, Love SB (1995) Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol 48:849–855
Keshava A, Chapuis PH, Chan C et al (2007) The significance of involvement of a free serosal surface for recurrence and survival following resection of clinicopathological stage B and C rectal cancer. Colorectal Dis 9:609–618
Sobin LH, Wittekind C (eds) (1997) TNM classification of malignant tumors, 5th edn. Wiley-Liss inc., New York
Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss inc., New York
Hamilton SR, Vogelstein B, Kudo S (2000) Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA (eds) World Health Organization classification of tumours. Pathology and genetics. Tumours of the digestive system. IARC Press, Lyon, pp 105–119
Chok KS, Law WL (2007) Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg 31:1485–1490
Losi L, Ponti G, Gregorio CD et al (2006) Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma. Pathol Res Pract 202:663–670
Cianchi F, Messerini L, Palomba A et al (1997) Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging? Dis Colon Rectum 40:1170–1175
Cianchi F, Palomba A, Boddi V et al (2002) Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 26:384–389
Krook JE, Moertel CG, Gunderson LL et al (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709–715
Acknowledgments
The authors are grateful to Ms. A. Kaps for her excellent technical support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pollheimer, M.J., Kornprat, P., Pollheimer, V.S. et al. Clinical significance of pT sub-classification in surgical pathology of colorectal cancer. Int J Colorectal Dis 25, 187–196 (2010). https://doi.org/10.1007/s00384-009-0801-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-009-0801-4